Skip to main content

Table 2 Health outcomes of rotavirus versus HPV vaccination among the 72 GAVI-eligible countries (following a single cohort)

From: Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden

Health outcome measures Rotavirus HPV
Target population (year 2010) 75,761,613 32,453,017
Number vaccinated 53,033,129 22,717,112
Number of lives saved per 1000 vaccinated 5.2 12.6
Deaths averted (r = 0%) 273,855 285,921
   Deaths averted by region (r = 0%) (% of total)   
AFR D, E 148,541 (54%) 89,524 (31%)
AMR A, B, D 1,808 (1%) 6,651 (2%)
EMR D 30,238 (11%) 12,611 (4%)
EUR B, C 3,257 (1%) 3,554 (1%)
SEAR B, D 85,579 (31%) 161,724 (57%)
WPR B 4,432 (2%) 11,857 (4%)
Years of life saved (r = 0%) 15,740,674 6,030,585
Years of life saved (r = 3%) 7,121,323 1,266,029
DALYs averted (r = 0%, uniform age weight) 15,767,404 6,191,573
DALYs averted (r = 3%, uniform age weight)* 7,146,859 1,304,426
   DALYs averted by region (r = 3%, uniform age-weight) (% of total)   
AFR D, E 3,748,499 (52%) 436,230 (33%)
AMR A, B, D 50,093 (1%) 34,160 (3%)
EMR D 784,703 (11%) 55,724 (4%)
EUR B, C 90,541 (1%) 21,296 (2%)
SEAR B, D 2,350,198 (33%) 707,996 (54%)
WPR B 122,825 (2%) 49,020 (4%)
DALYs averted (r = 0%, non-uniform age weight) 18,920,531 4,847,082
DALYs averted (r = 3%, non-uniform age weight) 8,121,119 1,148,295
  1. r = discount rate, DALY = Disability-adjusted life year.
  2. * Base-case